Optimum Amount and Mode of Physical Activity in Association with All-Cause and Cause-Specific Mortality: A Large Prospective Cohort Study

2021 ◽  
Author(s):  
Shuting Si ◽  
Bule Shao ◽  
Hui Liu ◽  
Wenliang Luo ◽  
MinJia Mo ◽  
...  
Keyword(s):  
Physical Activity ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Optimum Amount ◽  
Specific Mortality ◽  
Large Prospective Cohort Study ◽  
Large Prospective Cohort

scholarly journals Anthropometric Measures, Physical Activity, and Risk of Glioma and Meningioma in a Large Prospective Cohort Study

2011 ◽  
Vol 4 (9) ◽  
pp. 1385-1392 ◽  
Author(s):  
Dominique S. Michaud ◽  
Gerald Bové ◽  
Valentina Gallo ◽  
Brigitte Schlehofer ◽  
Anne Tjønneland ◽  
...  
Keyword(s):  
Physical Activity ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Anthropometric Measures ◽  
Large Prospective Cohort Study ◽  
Large Prospective Cohort

Urinary Incontinence and Hysterectomy in a Large Prospective Cohort Study in American Women

2002 ◽  
Vol 167 (5) ◽  
pp. 2088-2092 ◽  
Author(s):  
KRISTEN H. KJERULFF ◽  
PATRICIA W. LANGENBERG ◽  
LaVONNE GREENAWAY ◽  
JANE UMAN ◽  
LYNN A. HARVEY
Keyword(s):  
Urinary Incontinence ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
American Women ◽  
Large Prospective Cohort Study ◽  
Large Prospective Cohort

scholarly journals Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study

2020 ◽  
pp. annrheumdis-2020-217176 ◽  
Author(s):  
Zhi-Hao Li ◽  
Xiang Gao ◽  
Vincent CH Chung ◽  
Wen-Fang Zhong ◽  
Qi Fu ◽  
...  
Keyword(s):  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Digestive Disease ◽  
Proportional Hazards ◽  
Cox Proportional Hazards ◽  
Respiratory Mortality ◽  
All Cause Mortality ◽  
Specific Mortality ◽  
Large Prospective Cohort

ObjectivesTo evaluate the associations of regular glucosamine use with all-cause and cause-specific mortality in a large prospective cohort.MethodsThis population-based prospective cohort study included 495 077 women and men (mean (SD) age, 56.6 (8.1) years) from the UK Biobank study. Participants were recruited from 2006 to 2010 and were followed up through 2018. We evaluated all-cause mortality and mortality due to cardiovascular disease (CVD), cancer, respiratory and digestive disease. HRs and 95% CIs for all-cause and cause-specific mortality were calculated using Cox proportional hazards models with adjustment for potential confounding variables.ResultsAt baseline, 19.1% of the participants reported regular use of glucosamine supplements. During a median follow-up of 8.9 years (IQR 8.3–9.7 years), 19 882 all-cause deaths were recorded, including 3802 CVD deaths, 8090 cancer deaths, 3380 respiratory disease deaths and 1061 digestive disease deaths. In multivariable adjusted analyses, the HRs associated with glucosamine use were 0.85 (95% CI 0.82 to 0.89) for all-cause mortality, 0.82 (95% CI 0.74 to 0.90) for CVD mortality, 0.94 (95% CI 0.88 to 0.99) for cancer mortality, 0.73 (95% CI 0.66 to 0.81) for respiratory mortality and 0.74 (95% CI 0.62 to 0.90) for digestive mortality. The inverse associations of glucosamine use with all-cause mortality seemed to be somewhat stronger among current than non-current smokers (p for interaction=0.00080).ConclusionsRegular glucosamine supplementation was associated with lower mortality due to all causes, cancer, CVD, respiratory and digestive diseases.

Sign in / Sign up

Export Citation Format

Share Document